Selecting High-risk Early Breast Cancer Patients: What to Add to the Number of Metastatic Nodes?

By Perrone F.   Carlomagno C.   Lauria R.   De Laurentiis M.   Morabito A.   Panico L.   Pettinato G.   Petrella G.   Gallo C.   Bianco A.R.   De Placido S.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 41-46

Elsevier

Access to resources Recommend Favorite

Paclitaxel-containing High-dose Chemotherapy in High-risk Breast Cancer Patients

By Greinix Hildegard T.   Linkesch Werner   Seifert Manfred   Kubista Ernst   Czerwenka Klaus   Elahi Fariborz   Zielinski Christoph   Hoecker Paul   Steger Günther   Schulenburg Axel   Neumeister Geralt   Rabitsch Werner   Jakesz Raimund   Kalhs Peter  

Acta Oncologica, Vol. 39, Iss. 1, 2000-04 ,pp. : 47-52

Informa Healthcare

Access to resources Recommend Favorite

Postmastectomy radiotherapy in breast cancer with high risk of relapse: current and future approaches

By Gez Eliahu  

Future Oncology, Vol. 1, Iss. 6, 2005-12 ,pp. : 767-769

Future Medicine

Access to resources Recommend Favorite

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

By Pliarchopoulou K.   Kalogeras K.   Kronenwett R.   Wirtz R.   Eleftheraki A.   Batistatou A.   Bobos M.   Soupos N.   Polychronidou G.   Gogas H.   Samantas E.   Christodoulou C.   Makatsoris T.   Pavlidis N.   Pectasides D.   Fountzilas G.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer

By Eckhoff L.   Knoop A.   Jensen M.-B.   Ejlertsen B.   Ewertz M.  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 109-118

Springer Publishing Company

Access to resources Recommend Favorite